Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Bradley Pharmaceuticals, Inc.
Report 1: Bradley Pharmaceuticals, Inc. (NYSE:BDY) will feature its new Double Strength Flora-Q(R)2 dietary supplement at the annual Digestive Disease Week 2007 conference being held in Washington, D.C. from May 19-24, 2007. Flora-Q(R)2 is a high potency probiotic used to promote gastrointestinal health. It contains twice the amount of colony forming units (CFUs) of probiotic strains (at time of manufacture) than the Company's original Flora-Q(R)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.